Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filomena Conti

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
Biochimie|November 2, 2019
Impact of hepatitis C virus and alcohol, alone and combined, on the unfolded protein response in primary human hepatocytesCéline Hernandez, Etienne B Blanc, Véronique Pène, et al.
Cancer Research|May 2, 2013
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factorsHamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, et al.
Gastrointestinal Endoscopy|October 26, 2010
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter studyUlriikka Chaput, Olivier Scatton, Philippe Bichard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2007
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathwayLynda Aoudjehane, Philippe Podevin, Olivier Scatton, et al.
Hepatology (Baltimore, Md.)|June 22, 2013
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptorAudrey Clapéron, Martine Mergey, Lynda Aoudjehane, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2016
Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulinCorina Buta, Eva Benabou, Marie Lequoy, et al.
Disease Models & Mechanisms|February 26, 2020
Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosisLynda Aoudjehane, Jérémie Gautheron, Wilfried Le Goff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2022
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE studyFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Infectious Diseases Now|July 6, 2026
Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis useMaxime Mallet, Elisabeth Capelle, Jerome Dumortier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2019
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 YearsFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Biochimie|November 2, 2019
Impact of hepatitis C virus and alcohol, alone and combined, on the unfolded protein response in primary human hepatocytesCéline Hernandez, Etienne B Blanc, Véronique Pène, et al.
Cancer Research|May 2, 2013
Mitogenic insulin receptor-A is overexpressed in human hepatocellular carcinoma due to EGFR-mediated dysregulation of RNA splicing factorsHamza Chettouh, Laetitia Fartoux, Lynda Aoudjehane, et al.
Gastrointestinal Endoscopy|October 26, 2010
Temporary placement of partially covered self-expandable metal stents for anastomotic biliary strictures after liver transplantation: a prospective, multicenter studyUlriikka Chaput, Olivier Scatton, Philippe Bichard, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 7, 2007
Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathwayLynda Aoudjehane, Philippe Podevin, Olivier Scatton, et al.
Hepatology (Baltimore, Md.)|June 22, 2013
Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptorAudrey Clapéron, Martine Mergey, Lynda Aoudjehane, et al.
Journal of Experimental & Clinical Cancer Research : CR|August 13, 2016
Heregulin-1ß and HER3 in hepatocellular carcinoma: status and regulation by insulinCorina Buta, Eva Benabou, Marie Lequoy, et al.
Disease Models & Mechanisms|February 26, 2020
Novel defatting strategies reduce lipid accumulation in primary human culture models of liver steatosisLynda Aoudjehane, Jérémie Gautheron, Wilfried Le Goff, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|August 13, 2022
Five-year outcomes in liver transplant patients receiving everolimus with or without a calcineurin inhibitor: Results from the CERTITUDE studyFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Infectious Diseases Now|July 6, 2026
Pneumocystis jirovecii pneumonia after liver transplantation in France: retrospective multicenter case series and survey on prophylaxis useMaxime Mallet, Elisabeth Capelle, Jerome Dumortier, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|October 22, 2019
Early Switch From Tacrolimus to Everolimus After Liver Transplantation: Outcomes at 2 YearsFaouzi Saliba, Christophe Duvoux, Sébastien Dharancy, et al.
Pageof 13